Tempest Therapeutics (TPST) Q2 2026 Earnings

14MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-3.29
-2.29
-1.28
-0.28

Details

Expected EPS
-0.28
Actual EPS
-2.53
Surprise EPS
-2.25
Surprise Percent
+803.57%

Description

Tempest Therapeutics (TPST) has reported earnings of -2.53 per share for Q2 2026.

0 Comments

Share your thoughts